SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021404
Filing Date
2024-05-24
Accepted
2024-05-24 17:15:39
Documents
14
Period of Report
2024-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43878
  Complete submission text file 0001493152-24-021404.txt   263848

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE celu-20240521.xsd EX-101.SCH 3872
3 XBRL DEFINITION FILE celu-20240521_def.xml EX-101.DEF 26769
4 XBRL LABEL FILE celu-20240521_lab.xml EX-101.LAB 37000
5 XBRL PRESENTATION FILE celu-20240521_pre.xml EX-101.PRE 25393
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5993
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24985526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)